CuraLife

CuraLife's mission is to maximize patient health outcomes through nutraceutical offerings and a range of digital therapeutics. Inspired by people living with diabetes, CuraLife has built a powerful chronic disease management platform that offers therapeutic supplements, peer-to-peer support, behavior therapy, and virtual care. CuraLife solutions, commercially launched in 2017, have reached adoption in more than 50 countries. The company's CuraLin is a 100% natural glucose support supplement for people looking to maintain healthy blood sugar levels. It works by blending ancient Ayurveda practices with modern science and technology into a synergistic glucose support formula. Each CuraLin capsule is manufactured close to the source, using only premium ingredients. Secret production processes ensure that each capsule is highly potent and safe. All facilities are GMP and ISO 9001 certified, with independent quality controls ensuring safety and quality.

CuraLife was founded in 2013 by Ron Elul (Founder & CEO), Ofer Yigdal (Co- founder & Chief Portfolio Officer), Alberto Iore (Co-founder & Chief Business Officer), Tal Zimerman (Co-founder & Chief Growth Officer), Haviv Almog (Co-founder & Head of Product).

CuraLife operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, Digital Healthcare, Digital Therapeutics, with core technologies in Materials & Substances. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Life Sciences, Pharmaceuticals.

CuraLife is based in Ein Ganim Street 8, Tel Aviv-Yafo, Israel, Center District. The company also has offices abroad.